Moradi O - Search Results

1

Novel chitosan/γ-alumina/carbon quantum dot hydrogel nanocarrier for targeted drug delivery.

Karami MH, Pourmadadi M, Abdouss M, Kalaee MR, Moradi O, Rahdar A, Díez-Pascual AM. Karami MH, et al. Among authors: moradi o. Int J Biol Macromol. 2023 Nov 1;251:126280. doi: 10.1016/j.ijbiomac.2023.126280. Epub 2023 Aug 15. Int J Biol Macromol. 2023. PMID: 37591420 Free article.

2

Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis.

Ziaie S, Moradi O, Saffaei A. Ziaie S, et al. Among authors: moradi o. Iran J Kidney Dis. 2019 Sep;13(5):346. Iran J Kidney Dis. 2019. PMID: 31705754 No abstract available.

3

A Single-Centered Cohort Study on Favipiravir Safety and Efficacy in Pediatric Patients with COVID-19.

Rafiei Tabatabaei S, Moradi O, Karimi A, Armin S, Fahimzad A, Mansour Ghanaie R, Jamee M, Mousavizadeh A, Amini H, Mirrahimi B. Rafiei Tabatabaei S, et al. Among authors: moradi o. Iran J Pharm Res. 2022 May 17;21(1):e127034. doi: 10.5812/ijpr-127034. eCollection 2022 Dec. Iran J Pharm Res. 2022. PMID: 36710991 Free PMC article.

4

Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study.

Haji Aghajani M, Moradi O, Azhdari Tehrani H, Amini H, Pourheidar E, Hatami F, Rabiei MM, Sistanizad M. Haji Aghajani M, et al. Among authors: moradi o. Int J Clin Pract. 2021 Sep;75(9):e14434. doi: 10.1111/ijcp.14434. Epub 2021 Jun 12. Int J Clin Pract. 2021. PMID: 34080261 Free PMC article.

5

Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.

Haji Aghajani M, Moradi O, Amini H, Azhdari Tehrani H, Pourheidar E, Rabiei MM, Sistanizad M. Haji Aghajani M, et al. Among authors: moradi o. J Med Virol. 2021 Sep;93(9):5390-5395. doi: 10.1002/jmv.27053. Epub 2021 May 8. J Med Virol. 2021. PMID: 33913549 Free PMC article.

6

Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study.

Sistanizad M, Haji Aghajani M, Haghighi M, Amini H, Pourhoseingholi A, Taherpour N, Ziaie S, Salarian S, Moradi O. Sistanizad M, et al. Among authors: moradi o. Arch Acad Emerg Med. 2022 Jul 12;10(1):e56. doi: 10.22037/aaem.v10i1.1608. eCollection 2022. Arch Acad Emerg Med. 2022. PMID: 36033988 Free PMC article.

7

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine.

Lopes D, Lopes J, Pereira-Silva M, Peixoto D, Rabiee N, Veiga F, Moradi O, Guo ZH, Wang XD, Conde J, Makvandi P, Paiva-Santos AC. Lopes D, et al. Among authors: moradi o. Mil Med Res. 2023 Apr 27;10(1):19. doi: 10.1186/s40779-023-00453-z. Mil Med Res. 2023. PMID: 37101293 Free PMC article. Review.

8

Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adult Patients With and Without Type 2 Diabetes: A Cohort Study.

Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M. Khalili S, et al. Among authors: moradi o. Can J Diabetes. 2021 Aug;45(6):524-530. doi: 10.1016/j.jcjd.2020.10.014. Epub 2020 Nov 1. Can J Diabetes. 2021. PMID: 33339741 Free PMC article.

9

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.

Alavi Darazam I, Hatami F, Rabiei MM, Pourhoseingholi MA, Moradi O, Shokouhi S, Hajesmaeili MR, Shabani M, Irvani SSN. Alavi Darazam I, et al. Among authors: moradi o. Trials. 2020 Oct 26;21(1):880. doi: 10.1186/s13063-020-04812-2. Trials. 2020. PMID: 33106183 Free PMC article. Clinical Trial.

10

An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.

Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. Alavi Darazam I, et al. Among authors: moradi o. Int Immunopharmacol. 2021 Oct;99:107916. doi: 10.1016/j.intimp.2021.107916. Epub 2021 Jun 29. Int Immunopharmacol. 2021. PMID: 34224994 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters